naloxone hydrochloride injection, USP - CARPUJECT Principal Display Panel

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 1 mL Cartridge Label

1 mL Single-use Carpuject™
Sterile Cartridge Unit with Luer Lock

Rx only
NDC 0409-1782-03

Naloxone
Hydrochloride Injection, USP

RL-5579

0.4 mg/mL
PROTECT FROM LIGHT

For Intravenous, Intramuscular or Subcutaneous Use

Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 1 mL Cartridge Label

PRINCIPAL DISPLAY PANEL - 1 mL Cartridge Box

NDC 0409-1782-69
Rx only

1 mL Single-use

10 Carpuject™
Sterile Cartridge Units
with Luer Lock

Needle not included

SLIM- PAK™
Tamper Detection Package

Naloxone
Hydrochloride
Injection, USP
0.4 mg/mL

For Intravenous, Intramuscular
or Subcutaneous Use

Carpuject Cartridges are
to be used ONLY with
Carpuject Holders.

Hospira

PRINCIPAL DISPLAY PANEL - 1 mL Cartridge Box

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

naloxone hydrochloride injection, USP - CARPUJECT Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

INDICATIONS AND USAGE

Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene...